Board Meeting16 Oct 2026, 10:40 pm
Astec Lifesciences Board Meeting on Oct 26 to Approve Q2 Results
AI Summary
Astec Lifesciences Ltd has announced that its Board of Directors will convene on October 26, 2026. The primary agenda for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2026. This approval will follow a review by the company's Audit Committee. The company has also made the intimation available on its website.
Key Highlights
- Board meeting scheduled for October 26, 2026.
- To approve Q2 and H1 FY27 unaudited financial results.
- Results will be reviewed by the Audit Committee prior to board approval.
- Intimation available on the company website.
Price Impact
More from ASTEC